Hepcinat LP or Generic Harvoni: is made of ledipasvir 90mg and sofosbuvir 400mg and is once a day tablet taken orally for 84 days or 12 weeks. Treats patients with genotypes 1, 4, 5 or 6. Hepcinat LP is called Harvoni in the US, UK and EU.
Other Key Points About Harvoni and Hepcinat LP
The cure rate ranges from 93% to 99%
A 12 week treatment is prescribed for patients that have yet to be treated, regardless if they have cirrhosis or not.
Although clinical trials had high cure rates, Harvoni is not approved to fight HIV/HCV co-infections.
Harvoni and Hepcinat LP are leading drugs to cure HCV, but there is a small chance of side effects occurring during treatment.
Your Insurance Provider
Many insurancecompanies will cover the cost of Harvoni. But most people will probably not get approved by their providers. There has been quite a pushback from state providers such as Medicaid.
Some states force patients to go through a HCV qualification test. The test is really to prove that cirrhosis of the liver is present. If you have the proof your liver is in poor health, they will consider it life threatening and approve treatment.
Read the press release on generic Harvoni or Hepcinat LP produced in India, here.
*All hepatitis C treatments are licensed and authorized by Gilead Sciences. All manufacturing facilities are inspected by the US Food and Drug Administration.